Cargando…
Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II
In our previous study, we identified that a protein target, peroxiredoxin II (PrxII), is overexpressed in radioresistant MCF+FIR3 breast-cancer cells and found that its expression and function is associated with breast-cancer radiation sensitivity or resistance. Small interference RNA (siRNA) target...
Autores principales: | Diaz, Anthony Joseph Gomez, Tamae, Daniel, Yen, Yun, Li, JianJian, Wang, Tieli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929248/ https://www.ncbi.nlm.nih.gov/pubmed/24648762 http://dx.doi.org/10.2147/BCTT.S51378 |
Ejemplares similares
-
The role of peroxiredoxin II in chemoresistance of breast cancer cells
por: Wang, Tieli, et al.
Publicado: (2014) -
Increased activity of CHK enhances the radioresistance of MCF-7 breast cancer stem cells
por: YANG, ZHI-XUE, et al.
Publicado: (2015) -
Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells
por: LIU, ZHI-GANG, et al.
Publicado: (2011) -
Profiling Global Kinome Signatures
of the Radioresistant
MCF-7/C6 Breast Cancer Cells Using MRM-based Targeted Proteomics
por: Guo, Lei, et al.
Publicado: (2014) -
Peroxiredoxins in Cancer and Response to Radiation Therapies
por: Forshaw, Tom E., et al.
Publicado: (2019)